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Malaria remains a major cause of morbidity and mortality in tropical Africa. The northern 
KwaZulu areas of the Republic of South Africa are endemic for Pla"imodiumfalciparum malaria. 
The clinical morbidity produced hy this parasite in this area has not been studied since the work 
of Swellengrebel and DeMeillon in the early I 930's. These workers found a high prevalence as 
weH as a high parasite load in residents of this region prior to_ the institution of the present 
malaria control programme. Since 1984 malaria notifications have increased substantially in 
Natal/KwaZulu. The geographic spread and endemicity of the disease has changed in comparison 
to the situation prior to the introduction of the malaria control programme; transmission is now 
seasonal or epidemic rather than endemic. 
The aim of this study was to describe the clinical severity of falciparum malaria in the endemic 
areas of Natal/KwaZulu, and to assess the value of surnogate markers of infection. Fifty-nine 
patients were prospectively studied at a peripheral clinic during the peak malaria season in 1989; 
symptoms and signs of the infection, parasite load, haemoglobin values, leucocyte count, 
biochemical liver function tests and serum haptoglobins were recorded in all patients. The same 
haematological and biochemical parameters were also measured in 37 control subjects without 
malaria for comparative purposes. 
The commonest symptoms were persistent headache(IOO%), rigors(98%) and myalgia(93%). 
None of the patients presented in coma, pulmonary oedema, hypoglycaemia or algid malaria. 
Splenomegaly was found in 49%, hepatomegaly in 20% and mental confusion in 5%. Mean 
parasite load was 1. 71 % with 57 % of patients having parasite loads of < 1 % . Anaemia of 
< 10g/dl was significantly more frequent (p < 0.001) in the patient group than in the control 
group. Leucopenia (WCC < 4.0x!D9/l) was present in 12/50 (24%) patients compared to 2/37 
(5%) controls (p = 0.018). 
Hypoalbuminaemia was found in 64% compared to 13.5% (p < 0.001), hyperbilirubinaemia 
in 33% compared to 0% (p < 0.001), elevated lactate dehydrogenase (LDH) in 83% compared 
to 5 % (p < 0. 00 l )  of patients and controls respectively. Serum haptoglobins were reduced in 
44% of patients and 5% of controls (p < 0.001). AST was elevated in 15/58(26%) patients and 
3/37(8%) controls (p = 0.031), while ALT was elevated in 2/58(3.4%) patients and 0/37(0%) 
controls (p=0.254). The best biochemical predictor of malarial infection was an elevated LDH 
with a sensitivity of 83%; this test may be of value as a rapid indirect indicator. Both elevated 
bilirubin and elevated ALT were found in malaria patients but not in any of the controls. 
The results show a wide range of morbidity, without severe complications as presenting 
manifestations. Symptoms of infection occurred in the presence of low parasite loads; this 
suggests that there may be little or no immunity in this population. A greater proportion of 
patients had an elevated AST compared with ALT; this implies that the enzyme elevation 
originates from the parasitised erythrocyte rather than the hepatocyte. 
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In this research the statistical planning and analyses, and recommendations arising from these 
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The oh ligate intracellular protozoa of the genus Plasmodium is the cause of malaria; a disease 
which can have acute as well as chronic presentations. The four species of Plasmodia are P. 
malaria . P. vivax, P. falciparum, and P. ovate. It is generally agreed that malaria causes 
more human suffering than any other parasitic disease, and is the leading parasitic cause of 
morhidity and mortality in the world (Strickland 1986). More than 2.6 billion inhabitants of 
the tropics and subtropics are exposed to the risk of malaria infection (World Health 
Organisation 1985). Of the four Plasmodium species, P. falciparum is the most pathogenic. 
In previously non-exposed individuals who have no protective immunity the disease tends to 
be fulminant and death is likely to occur unless prompt treatment is given. By comparison 
to the other species, P. falciparum has the shortest incubation period and causes disease which 
is of the shortest duration (Bruce-Chwatt 1985). 
Approximately 110 million cases of malaria occur each year, of which 90 million are in 
tropical Africa (World Health Organisation 1990); global deaths are estimated at 
approximately 1 million per year usually from falciparum infection. There is considerable 
underreporting of diagnosed cases and the majority of patients with malaria are not seen by 
trained medical practitioners (Strickland 1986). 
The diseases' impact is hardest on Africa, where the climate, poverty, poor sanitation and 
ignorance all work in concert to provide an ideal breeding ground for the parasite. The 
prevalence in children exceeds 50% in many African counrries, with falciparum representing 
between 80% and 99% of cases (Wemsdorfer 1980); on this continent falciparum malaria 
kills more than one million children per year . A recent study by Greenwood er al ( 1987) in 
a rural area of the Gambia, estimated the overall mortality rate from malaria in children 
under the age of 5 years, to be 10 per 1000 per year, a figure remarkably similar to that 
obtained by Bruce-Chwatt (1952), 35 years earlier. The problem has been aggravated by the 
development of resistance to a wide range of insecticides and chemotherapeutic agents by the 
Anopheles mosquito and P. falciparum respectively. 
The annual number of malaria notifications in South Africa increased from 3.6 per 100 000 
in 1957 to 30.0 per 100 000 in 1987 (Kustner 1988). The northern KwaZulu areas of Natal 
are endemic for falciparum malaria (Sharp et al 1988). This area of South Africa experienced 
an outbreak of falciparum malaria in late 1987 and early 1988 (Hansford and Muller I 990); 
clinical malaria has not been studied in this region since the work of Swellengrebel et al in 
1931. 
The malaria conrrol programme in Natal/KwaZulu as a whole is considered to be highly 
effective. This is illustrated by the low case rate (range 7.0 - 26.8/100 000) between 1976 
and 1983 (Kustner 1988) and the successful agricultural and industrial development of large 
parts of the province in conrrast to the situation in the late 1920s and early 1930s (Sharp et 
al 1988). 
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Swellengrebel et al ( 1931) showed that there was a high prevalence of infection in this area, 
with 94 per cent of toddlers being parasite carriers, of whom 59 per cent were heavy ones. 
They concluded that there was a high level of immunity in the population which manifested 
among adults in three ways: (1) absence or rareness of malarial fever; (2) decrease of splenic 
enlargement; (3) decrease in the number of parasite carriers, all in contrast to a much 
suffering childhood. They concluded that "the more endemic conditions depart from the type 
of continuous infection, the more malaria becomes seasonal and the less chance is afforded 
for this state of immunity to establish itself. If malarial conditions are of the epidemic type, 
ie., fever years being separated by longer or shorter successions of healthy years, the chances 
of immunization become still less." This study is an attempt to describe the clinical features 
of malaria and to ascertain whether these have changed over the decades, noting the 
introduction of the present malaria control measures. This would assist in establishing whether 
the high level of semi-immunity previously described still exists in residents of this endemic 
region. The study described in this thesis was conducted in the northern KwaZulu areas, as 
this region has the highest prevalence of the disease. 
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CHAPTER 2 
REVIEW OF LITERATURE 
2.1 EPIDEMIOLOGY OF MALARIA 
2.1.1 Epidemiological terminology 
2.1.1.1 Malaria parasitological and clinical rates 
Malaria incidence is the number of new clinical cases occurring over a given period of time 
in relation to the unit of population in which they occur. Malaria prevalence is the number of 
cases of infection and disease existing per defined population during a given time interval. The 
malaria morbidity rate is the number of malaria cases per 1000 or 10 000 population per year. 
The malaria mortality rate is the number of deaths due to malaria per 100 000 population per 
year. The spleen rate is the proportion of children two to nine years of age with enlarged 
spleens; if adults or other age groups are included then this should be specified. Parasite rate 
is the proportion of persons in a defined group on a given date with microscopically proven 
parasitaemia. The transmission index is the proportion of infants less than one year with 
parasitaemia (Spencer 1986). 
2.1.1.2 Endemicity 
Malaria is defined as endemic when there is a measurable incidence both of cases and of natural 
transmission over a succession of years ( Molineaux 1988). The degree of endemicity of malaria 
is determined by examination of a statistically significant population sample and has been 
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assessed and classified as follows (World Health Organisation 1951; Metselaar and van Thiel 
1959): 
1. Hypoendemic - spleen rate or parasite rate of 0% to 10% in children 2 to 9 years
old. 
2. Mesoendemic - spleen rate or parasite rate of 11 % to 50 % in children 2 to 9 years
old. 
3. Hyper-endemic - spleen rate or parasite rate consistently over 50% in children 2 to
9 years old. 
4. Holoendemic - spleen rate or parasite rate of more than 75 % in children 2 to 9 years
old: the adult spleen rate is low and the parasitaemia rate in infants is high. 
Epidemics are defined by an incidence of new cases clearly in excess of the expected 
(Molineaux 1988). Any transmission in a previously malaria-free area is obviously in excess of 
the expected and constitutes an epidemic by the above definition with the proviso that, 
traditionally, small epidemics are usually called outbreaks. An increase in transmission in areas 
where. the level of transmission is usually low, either naturally or under the impact of control 
activities, may or may not be labelled 'epidemic' depending on the magnitude of the excess of 
cases and on the rate at which the excess develops, as well as on the availability and 
interpretation of previous data from which to calculate the 'expected'. Possible precipitating 
factors of malaria epidemics include ( Molineaux 1988): (i) an increase in vectorial capacity, (ii) 
immigration of infective persons, (iii) immigration of non-immunes, and (iv) drug resistance. 
Actual epidemics are commonly caused by a combination of several of the factors. 
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2.1.1.3 Malaria stability 
Malaria situations are extremeiy diverse with respect to resistance to change. At one extreme, 
the prevalence of infection is extremely high and only little affected even by relatively large 
natural or man-made changes in the factors that influence transmission (eg. vector density). At 
the other extreme, the prevalence of infection varies widely and is very sensitive to even 
relatively small natural or man-made changes in the factors of transmission. Stability increases 
with the endemicity level. 
Stable endemic malaria is present when there is a high degree of natural transmission with little 
change from season to season; epidemics are unlikely. Stable malaria is present in many 
countries in sub-Saharan Africa. In unstable malaria the incidence of malaria varies 
considerably from year to year, collective immunity is low and epidemics are likely. This pattern 
is typical of marginal areas of malaria distribution with relatively short transmission seasons eg. 
northern Natal. 
2.1.2 Africa south of the Sahara 
The prevalence of malaria has remained unchanged in most malarious areas and P. falciparum 
is the predominant species, being present alone or with another species in about 85 % of malaria 
infections. Of a population of about 421 million, 373 million live in malarious areas; 37 million 
live in hypoendemic areas, 112 million inhabit mesoendemic zones and 224 million live in areas 
where malaria is hyperendemic to holoendemic (Spencer 1986). Transmission is particularly 
intense in rural areas of west Africa where the risk of infection is exceedingly high; it has been 
6 
shown that in the Gambia, children under the age of 7 years experienced about one clinical 
episode of malaria per year (Greenwood et al 1987). 
2.1.3 Epidemiology of maJaria in northern Natal 
Malaria remains prevalent within the horders of Natal province, in spite of the current measures 
aimed at controlling the disease. During the eight year period 1976-1983 an average of 644 cases 
of malaria was reported annually in Natal (range 208-1324 cases per annum) (Fig. l)(Sharp 
199 l). During the following five years ( 1984-1988) this increased to 3846 cases per annum 
(range 2193-7530 per annum). 
The geographic spread and endemicity of the disease have changed somewhat in comparison to 
the situation prior to the introduction of the malaria control programme, when the 3 
northern districts of Ingwavuma. Ubombo and Hlabisa (Figure 2) were classified as endemic 
malaria areas, with seasonal epidemics occurring to the south and inland of these districts (Sharp 
1991); the highest prevalence of infected carriers being in infants and toddlers and the prevalence 
decreasing with age. In fact the severity of the disease was such, that "toddlers were infected 
without exception" (Swellengrebel et al l 931). Sharp ( 1991) has shown that although very little 
transmission of the disease occurs outside these three districts, which lie in the KwaZulu area 
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FIGURE 1 : Comparative annual malaria case totals for the Republic of South Africa and Natal 
province for the years 1976 - 1988 (Source: B.L. Sharp 1991 ). 
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The monthly totals for those persons reporting to hospitals. clinics, and general practitioners with 
malaria may be used to determine the malaria transmission season. The disease shows a distinct 
seasonality with transmission starting in early summer and reaching a peak during the months 
of April and May and the detection of infected patients virtually ceasing in July (Sharp et al
1988). Recent findings, derived from official notifications (KwaZulu Health and Department of 
National health and Population Development), show that the numbers of infected individuals in 
the different age categories are representative of the population structure, implying that the whole 
population is at risk, a situation seen during epidemic malaria (Sharp et al 1988). This change 
is considered to be a direct result of the longstanding successful control programme. The 
endemic malaria area is consequently now considered to lie to the north in Mozambique where 
no formal malaria control programme has heen in effect for more than IO years. 
These patients presenting to hospitals, clinics and general practitioners would mainly be non­
immunes who as a result of infection developed clinical symptoms. These findings are in keeping 
with what is expected from an area that encompasses the most southern distribution in Africa of 
a mainly tropical disease. 
2.2 THE MALARIA CONTROL PROGRAMME IN NATAL 
In 1928-29 a large number of employees of the sugar mills and plantations of Natal were 
afflicted with malaria. Of an estimated 6 000 Europeans at risk, 7 died; of 20 000 Asians, 151 
and of 215 000 blacks, 2 600 died (Nethercott 1974). At the invitation of the government, 
Professor Swellengrebel of the University of Amsterdam visited Natal in 1930 to investigate the 
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malaria situation in the Union of South Africa (Swellengrebel et al 1931 ). As a result of his 
report, intensive anti-malaria measures were implemented. 
The control programme was intended to include all the malaria areas of the province with the 
exception of the 3 northern districts, Ingwavuma. Ubombo and Hlabisa. These were excluded 
on the recommendation of Swellengrebel ( 1931), because they were 
highly endemic areas and it was feared that the natural immunity 
of the population would diminish if a control policy was introduced. 
Anti-larval measures using oil and Paris green (copper acetoarsenite) were introduced in 1932 
and continued to be the main means of control until 1946. In 1934, pyrethrum was introduced 
as an intra-domiciliary knockdown insecticide. In 1946 the use of pyrethrum was discontinued 
and was replaced by DDT, both for house spraying and larviciding. This continued until 1953, 
when these measures were graduaUy extended to include the 3 northern districts, beginning with 
the spraying of all habitations within a three mile radius of mission stations and police camps. 
Anti-larval measure were abandoned in 1956. In the same year, malaria became a notifiable 
disease in the Union of South Africa. Total coverage of all homes with a residual insecticide was 
achieved for the first time in the northern districts of Natal in October 1958. 
10 

2.3 NATURALLY-ACQUIRED IMMUNITY TO MALARIA 
The relationship between the parasite and the immune response of the host to it is one of the 
main determinants of the distribution of malaria (Bruce-Chwatt I 985). In general, persons 
repeatedly exposed to malaria in endemic areas develop a degree of immunity; they become 
semi-immune. The immune response depends on humoral immunity and ceJl-mediated immunity; 
however, no clear picture of the mechanisms of naturally-acquired immunity to malaria has yet 
emerged (Day and Marsh 1991). The acquisition of immunity aids in recovery from the initial 
malaria infection; subsequent infections increase the level of immunity. The severity of clinical 
manifestations, parasitaemia, the number of patent parasitaemic episodes from one inoculation 
and the production of gametocytes are all reduced by immunity (Spencer 1986). 
The immunity which develops is species- and strain- and stage-specific (McGregor 1986). It is 
also dependent upon the presence of repeated infection. Loss of immunity results from loss of 
exposure. Thus, persons leaving endemic areas may develop symptoms after some months. 
Severe malaria may occur in previously immune adults who return to a malarious area after 
living _for some time in a non-endemic one. 
Naturally-acquired immunity to falciparum malaria has been shown to be closely related to the 
development of antibodies to circumsporozoite (CS) proteins (Hoffman et al 1986; Day and 
Marsh 1991). Levels of CS antibody have been shown to increase with age in malaria-endemic 
areas in Africa (Campbell et al 1987). Antibodies to malaria sporozoites have also been shown 
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to be lower in patients with cerebral malaria than in patients with acute uncomplicated malaria 
(Tapchaisri et al 1985). 
2.4 CLINICAL MALARIA 
The immune status of populations in areas of unstable malaria develops differently to that where 
there is stable transmission (World Health Organisation 1988). As a consequence: 
* the general population is non-immune;
* most cases of disease occur in young adults. predominantly in males, upon taking up
occupations requiring forest work;
* severe and complicated infections are seen in adults. Pregnant women, especially
primiparae, are at extremely high risk of serious and fatal infections;
* symptoms of malaria may begin before parasitaemia is microscopically detectable. The
presence of parasitaemia, even at a very low level, usually implies clinical illness.
The classical clinical picture of symptomatic malaria is well-known. Assessment of the clinical 
symptoms, particularly the presence of fever, forms the basis of malaria diagnosis at the village 
' 
level and also at the first referral level in many areas. The World Health Organisation and 
UNICEF currently recommend treatment of clinical malaria by village health workers 
(Greenwood et al 1988). However, fever alone is a very imprecise means of diagnosis and 
investigations conducted in tropical Africa showed that only about 46 % of patients so diagnosed 
were actually suffering from the disease. On the other hand, some 15 % of patients clinically 
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diagnosed as suffering from tevers due to diseases other than malaria were in fact proven to have 
clinically manifest plasmodial infections (Baudon et al 1985). 
There is no clinical parameter which used on its own would permit a reliable diagnosis of 
malaria and, at present. microscopic detection of parasites appears to be the most reliable method 
for making a definitive diagnosis. Because of the protean manifestations of the disease the 
differential diagnosis of malaria in the tropics includes diseases such as typhoid fever, 
meningitis, encephalitis, metabolic disturbances, viral hepatitis, leptospirosis, septicaemias, and 
many other multisystem diseases (Gilles 1988). 
Light microscopy is not available in many areas and health workers require guidelines to 
improve the clinical diagnosis of malaria. Furthermore, to prevent mortality it is essential to 
establish criteria that would ensure the appropriate treatment as well as timeous referral of 
patients suffering from severe and complicated forms of the disease. A definition of severe 
malaria to be used by health workers who have different grades of clinical competence, as 
established by the World Health Organisation, may facilitate the diagnostic and referral 
procedure (Warrell et al 1990). 
2.5 BIOCHEMISTRY AND HAEMATOLOGY 
Today, discussion of advances in the diagnosis of malaria is conducted in the languages of 
molecular biology and immunology. The measurement of various biochemical and 
immunological parameters may be used as indirect indicators of many diseases but their 
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application to the diagnosis of malaria has not been adequately explored (World Health 
Organisation 1988). If such cheap and reliable tests could be developed they would be a valuable 
diagnostic tool in areas where the provision of reliable microscopic facilities is not possible. An 
ideal diagnostic test - sensitive, specific, reproducible, inexpensive, and rapid and simple to 
perform - has yet to be developed (Bruce-Chwatt 1987). 
Malaria, especial1y due to P. falciparum is a disease in which clinical and biochemical changes 
are produced by parasite-induced blood destruction as well as cytokine release. These changes 
are usual1y quantitatively related to the degree of blood destruction. In addition, liver function 
is almost always disturbed during the acute phases of infection (World Health Organisation 
1988). Pathological changes in hepatic function are usually manifest in acute malaria even when 
parasitaemia is low or moderate. Major disturbances of renal function are seen in severe and 
complicated malaria and malarial nephropathy, but rarely in non-complicated falciparum malaria. 
However, a mild proteinuria is very common in acute malaria. Immune processes, in conjunction 
with hepatic dysfunction, often leads to a significant decrease of the albumin/globulin ratio. 
Tests for urobilin, albumin and haptoglobin degradation products in urine as wel1 as for lactate 
dehydrogenase, transaminases and haptoglobin levels in blood may be potential indirect 
indicators of acute malaria (World Health Organisation 1988). Haptoglobin is an alpha-2 globulin 
which binds free haemoglobin. Low serum levels are therefore found in haemolytic conditions. 
Hypohaptoglobinaemia has recently been shown to be a valuable epidemiological and clinical 
indicator for malaria (Rougemont et al 1988, Trape et al 1985). Serum bilirubin often shows a 
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moderate increase in malaria. hut bilirubinuria is rare except in complicated malaria with major 
hepatic involvement. Similar changes are also observed in patients suffering from viral hepatitis 
when hilirubin values are usually high in hoth hlood and urine. 
Anaemia is a common feature of malaria and the degree of anaemia is often far in excess to that 
accounted for by the removal of infected cells alone (Pasvol 1986). Leucopenia is also a frequent 
accompanying characteristic with leucocytosis suggesting a complication or an unrelated disease 
(Reiley and Barrett 1971). 
2.6 SOUTH AFRICAN STUDIES ON CLINICAL MALARIA 
Swellengrebel ( 1931) commented that: 
"It is a generally accepted idea that in an area of high malarial endemicity, the 
adult indigenous population acquires a certain degree of immunity by being 
exposed to ever recurrent infections from early childhood onward. This state of 
immunity shows itself among adults in three ways: (1) absence or rareness of 
•. malarial fever; (2) decrease of splenic enlargement; (3) decrease in the number 
of parasite carriers, all in contrast with a too much suffering childhood. The more 
endemic conditions depart from the type of continuous infection, the more malaria 
becomes seasonal and the less chance is afforded for this state of immunity to 
establish itself. If malarial conditions are of the epidemic type, i.e., fever years 
being separated by longer or shorter successions of healthy years, the chances for 
immunisation become still less." 
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He observed in the African population that: 
" ... as far as the distribution of crescents is concerned in relation to age. The 
highest percentage of crescent-carriers and the most prolific crescent-carriers are 
to be found among the young children ............. the intections in early age are 
much heavier in our observations, the 'toddler-age' is infected, almost without 
exception. and the parasite rate amongst adults decreases ........ " 
These early observations are typical of an area where the level of naturally-acquired immunity 
to malaria is high. Two other studies (Eales 1972; Jairam et al l 990) describing the clinical 
illness were both retrospective studies at teaching hospitals; both studied mainly immigrants 
visiting South Africa or locals returning from an endemic area. 
2. 7 CHLOROQUINE-RESISTANT MALARIA
Reports of resistance to P. falciparum parasites to chloroquine, first observed in 1960-61 in 
Brazil and Colombia (Bruce-Chwatt 1980), were of great consequence since together with 
quinine these are the most valuable drugs for the treatment of acute malaria. Further reports on 
drug resistance came from Thailand, Malaysia, Cambodia, Philippines, Indonesia, Viet-Nam, 
Laos, Burma and other areas of south-east Asia. Chloroquine-resistant P. falciparum malaria was 
first reported from Africa in 1979 and has since spread throughout most of southern Africa 
(Spracklen and Whittaker 1984). 
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Resistance of P. falciparum to chloroquine was first detected in Natal in I 985 (Herbst et al 
1985) and studies completed by Freese et al ( 1988) found 94 % of the isolates tested to be 
resistant, with only 74% being inhibited at > =32 pmol/ul of cWoroquine, indicating RIil 
resistance (World Health Organisation I 984). In February 1988, the authorities responsible for 
malaria control in Natal changed to using pyrimethamine-sulphadoxine (Fansidar/Roche) for the 
treatment of the asexual stages of P. falciparum infection, coupled with the use of primaquine 
as a gametocytocide (Dr. M. Short, personal communication). 
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CHAPTER 3 
PATIENTS AND METHODS 
The epidemiology and pattern of transmission of falciparum malaria in northern Natal has 
changed from one of intense transmission in the earlier decades of this century, to seasonal 
transmission in the last few decades. This is largely a result of the successful control 
measures implemented during the 1950s (Nethercott 1974). Consequent to the lack of 
repeated exposure to infection. the degree of acquired immunity to the parasite is likely to 
have decreased. Furthermore, the annual number of malaria notifications in this region has 
increased in the latter half of the 1980s: chloroquine resistance has also been documented 
during this period (Herbst et al 1985; Freese et al 1988). 
The objective of this dissertation was to determine whether changes in epidemiological 
patterns have had an impact on the clinical features of falciparum malaria infection on the 
locaJ population in northern Natal. To achieve this objective we studied the effects of the 
disease on a group of confirmed patients presenting to a primary health care facility for 
medical attention. 
The second objective was to assess the value of haematological and biochemical parameters 
as rapid indirect indicators of P. falciparum infection. For this part of the study a control 
group of healthy volunteers from the study area was also studied for comparison. 
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This was a cross-sectional study conducted during March and April ( 1989), which is the peak 
season for malaria in this region. It was a field study performed in the Ingwavuma district 
of northern KwaZulu (district 1 in Figure 2). The patients were studied at the Ndumu clinic, 
which is close to the Mozambican border. This is a primary health care centre and a point 
of first contact for the population in this district. It is staffed by nurses and paramedics with 
no full-time medically-qualified staff. 
3.1.1 PATIENTS 
All patients in the study were diagnosed by passive detection, i.e. they presented themselves 
for medical attention as a result of symptoms. Actively-detected patients are those in whom 
a diagnosis of malaria is made as a result of routine blood-smear examination performed 
during mass blood screening. 
A research team travelled to the Medical Research Council field station in Jozini for periods 
of one week at a time during the peak malaria season. This team consisted of a medical 
research officer (the author), Dr. Brian Sharp (researcher at the Research Institute for 
Diseases in a Tropical Environment), a nursing sister, and a technologist. From there the 
team travelled daily to Ndumu Clinic, which is approximately 75 kilometres from the field 
station. 
The nursing staff at the clinic referred suspected malaria patients to us for detection of 
asexual forms of P. falciparum on thin blood smears. Microscopic examination was carried 
out using a compound microscope and a combination of lenses which provided a total linear 
magnification of l 000 for oil immersion microscopy. The microscope was powered by a 
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generator and the slides were stained with Giemsa. A total of 59 patients of > =5 years of 
age with confirmed P. jalciparum infection was obtained by sequential sampling and included 
in this study. Patients under 5 years were excluded because of the difficulty of obtaining 
adequate amounts of blood for haematological and biochemical analysis. Informed consent 
was obtained from all patients, and from the guardians in the case of minors. 
A history of relevant symptoms was obtained from each patient. Thereafter a thorough 
clinical examination was performed: special emphasis was placed on clinical signs of malaria. 
Guidelines set out (Characteristics of severe malaria and their identification at different levels 
of the health services) by the WHO Malaria Action Programme (1986) (Warrell et al 1990) 
were closely adhered to when making the clinical assessment. Appendix 1 is an example of 
a clinical data sheet. In the majority of patients, the duration of the illness was not recorded; 
in those in whom it was available, it was thought to be unreliable as many patients were 
unsure of the duration. 
In each patient thin blood smears were quantitatively examined to estimate the parasite load. 
In addition, urine samples from the patients were tested for the presence of blood and protein 
using dipstix (Ames) and blood glucose was measured on a fingerprick specimen using a 
glucometer (Ames). Blood samples were drawn by venepuncture for later haematological and 
biochemical analysis. 
All patients were treated by the KwaZulu health authorities with sulphadoxine-pyrimethamine 
(Fansidar/Roche) 3 tablets stat for adults and adjusted according to weight for minors. 
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Patients with greater severity of illness were referred to Mosvold Hospital, a district hospital 
in this area, for inpatient management. 
3.1.2 CONTROLS 
Thirty-seven volunteers aged 5 years and above served as controls. This group consisted of 
healthy subjects living in the same endemic area and were studied during the same malaria 
season. They had not suffered from malaria during this season, and their blood smears were 
negative for Plasmodium spp. Blood was drawn after informed consent for biochemical and 
haematological measurements. 
3 .2 PROCESSING OF BLOOD SAMPLES 
Haemoglobin (Hb) estimation and white cell count were performed using a Cell-Dyne 
analyzer. Serum was separated from cells and stored in small aliquots at -20"C for analysis 
at the biochemistry laboratory at King Edward VIII Hospital, Durban. All serum samples 
were analyzed for liver function tests using an autoanalyser (Beckman Instruments Inc., Brea, 
CA, USA); serum haptoglobin levels were also measured, using a commercially available kit 
(Beckman Array Protein System, CA, USA) by the principles of rate nephelometry. 
3.3 DATA STORAGE AND ANALYSIS 
D-Base Illplus was used for data storage and Statsgraphics employed for data analysis.
Statistical assistance was provided by the Institute of Biostatistics of the Medical Research 
Council. The Student's t-test was used for comparison of means and the chi-squared test for 
comparison of categoric data. Where the expected cell sizes were less than five in the 2x2 
case. the Fischer's exact test was used. 
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3.4 ETHICAL APPROVAL 
This was granted by the Ethics and Professional Standards Subcommittee of the University 
of Natal. 
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4.1 DEMOGRAPHIC DAT A 
CHAPTER 4 
RESULTS 
Of the 59 patients studied. 33 were female and 26 male. Their mean age was 22 years with 
a range 5 to 60 years. The control population consisted of 27 females and IO males, with a 
mean age of 26 years, range 5-60 years. 
4.2 SYMPTOMS AND SIGNS 
Figure 3 shows the frequency of occurrence of symptoms. Persistent headache, rigors and 
myalgia were the most common symptoms; these were present in I 00%, 98 % , and 93 % of 
patients respectively. 
Seventy-three per cent of patients complained of fever and their mean temperature was 
38.5°C, with a range of 36.8°C to 40.5°C. Mild jaundice was detected in 2 patients. The mean 
pulse rate was 102/minute: there was no patient with algid malaria, although systolic blood 
pressure was less than I OOmmHg in 21 (35.6%) patients. 
Splenomegaly, ranging from I cm. to 8 cm.(mean 2.4cm.), was found in 29(49%) patients. 
Hepatomegaly was detectable in 12(20.3%) patients; the mean increase in liver size was 2 
cm. with a range from I to 4 cm. 54% of patients were found to be dull or drowsy and 3
patient-; (5%) were confused. None of the patients presented with hypoglycaemia and the 
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mean hlood sugar was 6.4 mmol/1, ranging from 3.6 to 11.4 mmol/1. No patient presented 

































FIGURE 3: Bar graph of symptoms in 59 patient.Ii with P. fulciparum malaria. 
Proteinuria was detected in 95% of patients, however in the majority (81.3%) this was mild 
(trace to + ). Haematuria was detected in 59%; in 14 of them this was severe ( + + + + ). 
ohserved three patients with cerehcllar signs and acute falciparum malaria. All three 
patient.Ii had severe gait and trun<.:al araxia. One patient had tu he ferried tu the field station 
in a whcclharrow as he was unahlc tu walk. ft,nothcr was unahlc tu walk unaided through a 
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doorway hecause of his ataxia (Soni and Sharp I 992). A third patient was also noticed to 
have nystagmus and suffered a grand mal seizure while being examined. All patients had ring 
forms of the parasite in their blood films. together with fever and other manifestations of 
acute P . .falciparum infection. Only the first patient had taken Chloroquine, and this was in 
prophylactic doses only. Unfortunately, it was not possible to perform any special 
investigations on these patient'i and follow-up, except for the first patient who recovered 
completely, is unavailable for the latter two patients. 
4.3 PARASITE LOAD 
The median parasite load was 0.64% (of erythrocytes infected) on thin smear with a range 
of 0.01 to 10.74%. The majority of patients (57%) had parasite counts of< I%. Five (8.5%) 
patients had hyperparasitaemia ie. > 5 % of erythrocytes infected. Plate 1 shows a blood film 
of a patient with a heavy infection showing the asexual forms of the parasite (trophozoites). 
4.4 HAEMATOLOGY 
Haemoglobin was measured in 50 patients and the mean was I0.8g/dl (range 6.9 to 16.9g/dl). 
The mean for the control group was 12.1 (range 8 to 14.6g/dl). This difference was 
statistically significant (p = 0.0019). 35/50 patients compared to 16/37 controls had a Hb of 
< 12g/dl (p=0.012). From Figure 4 it is apparent that a significantly (p < 0.001; chi-squared 
= 13.47) more severe anaemia (under IOg/dl) occurred in patients (40%) than in controls 
(5%). There was no correlation hetween the parasite load and haemoglobin (R = -0.004). 
There was no statistical difference (p = 0.267) hetween the mean leucocyte count in the 
patient group (6. lx l09/I) and the control group (6.7x109/I). The leucocyte count in the 
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PLATE 1 : Photomicrograph of a thin smear of blood in a patient with heavy infection 
showing trophozoites (ring forms) of P. falciparum (X 1000). Some erythrocytes 
are infected with more than one ring form. 
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patients had a wide scatter with a range of 2.3 to 20x 109/1. Leucopenia (WCC < 4.0xl09/l) 
occurred significantly more frequently in patients (12/50) than controls(2/37)(p=0.018). 
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FIGURE 4: Haemoglobin values in 50 patients and 37 control subjects. 
4.5 BIOCHEMISTRY 
Table I shows the result� of hiochemical liver function tests in 58 patients and the 37 control 
subjects. Abhreviations and normal values used in this table arc the following: 
AST : Aspartate transaminase; Normal 10-42 IU/1 
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ALT: Alanine transaminase: Normal 10-60 IU/1 
LOH : Lactate <lehydrogenase: Normal 266-500 IU/1 
Albumin : Normal 35-50 g/1 
Biliruhin : Normal 0-17 umol/1 
No. reduced and no. elevated in Table I refers to below and above the normal range 
respectively. 
More patients had hypoalbuminaemia, hyperbilirubinaemia, and increased LOH and AST 
enzymes than control subjects (Table I); the difference was statistically significant. However, 
only 2 patients and no controls had an elevated ALT. There was no correlation between 
parasite load and bilirubin (R = 0.186), AST (R = 0.051), LOH (R = 0.196) or ALT (R 
= 0.013). Of the I 9 patients who had elevated bilrubin levels, 12 had a direct (conjugated) 
bilirubin result which was greater than the total bilirubin. It is unclear whether this was due 
to a faulty reading on the autoanalyser or a printer malfunction; it was therefore not possible 
to investigate unconjugated hyperbilirubinaemia as a measure of haemolysis. 
4.6 HAPTOGLOBINS 
The normal values for serum haptoglobins is O. 13 to I . 63 g/1. 26 of 59 ( 44 % ) patients had 
reduced levels of haptoglohins ( < 0. 13 g/1), including 6 patients in whom the level was too 
low to be measured; a decrease in haptoglobin levels was seen in only 2 of 37 controls (5 % ) . 
This difference was highly significant (p < 0. 00 I). 
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Table I: Biochemical liver function tests in 58 patients with P. falciparum malaria and 37 
control subjects. 
TEST PATIENTS CONTROLS p 
(n = 58) (n = 37) VALUE 
Albumin (g/1) 
Mean (range) 32 (20-45) 39 (29-46) <0.001 
No. reduced (%) 37 (64) 5 ( 13.5) <0.001 
Bilirubin (umol/1) 
Mean (range) 16 (6-47) 6 (3-12) <0.001 
No. elevated(%) 19 (33) 0 (0) <0.001 
AST (IU/1) 
Mean (range) 37(10-139) 26 ( 10-51) 0.001 
No. elevated(%) 15 (26) 3 (8) 0.031 
ALT (IU/1) 
Mean (range) 21 (7-67) 12 (7-20) <0.001 
No. elevated(%) 2 (3.5) 0 (0) 0.254 
LOH (IU/L) 
Mean (Range) 79 l (273-2257) 400 (217-692) <0.001 
No. elevated ( % ) 48 (83) 2 (5) <0.001 
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CHAPTER 5 
DISCUSSION OF RESULTS 
This study differs from other clinical studies in the Republic of South Africa (Eales 1972; Jairam 
et aL 1990) in two ways. Firstly it was performed at a primary health care centre rather than a 
tertiary referral hospital; and secondly it reflects the morbidity of P. faLciparum malaria in 
residents of the region (indigenous malaria) rather than immigrants or South Africans returning 
from travels elsewhere in Africa. Both the above studies (Eales 1972; Jairam et aL 1990) were 
retrospective; these were descriptions of imported malaria in white patients and neither described 
any cases of indigenous malaria. In the study by Jairam et al ( 1990) the 3 regions where the 
patients most often contracted malaria were Botswana, Malawi and Zimbabwe; none of their 
patients were thought to have contracted the disease in South Africa. In Eales's study (1972) at 
Grootte Schuur Hospital, only 2 of 47 patients had contracted malaria in South Africa during 
holiday visits to the Kruger National Park. 
5. 1 CLINICAL
It is apparent from the result'i described in Chapter 4 that none of the patients presented with 
severe complications of falciparum malaria, such as coma, pulmonary oedema, hypoglycaemia 
or algid malaria. Symptomatic infection in the presence of low parasite loads in most patients 
suggests that there may be little or no immunity to P. faLciparum in this population. Field ( 1949) 
showed that poor outcome was directly related to high parasite density; he commented that the 
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parasite density was "the most reliable indication of severity in all hut very few cases"; however 
the reverse was not true. This implies that the level of parasitaemia is not the only factor 
determining malaria mortality and morbidity. Another important factor is the degree of immunity 
which the individual possesses to the parasite. 
The majority of patients in this study (57 % ) had less than I % of erythrocytes infected, yet were 
sufficiently symptomatic to warrant seeking medical attention: the median parasite load was also 
low (0.64%). This was certainly not the case in the study area in 1931 (Swellengrebel et al 
1931). The picture described by Swellengrebel et al is similar to those of other hyperendemic 
areas such as Gambia (McGregor 1964), Kenya (Garnham 1948), Liberia (Miller 1958) and the 
Sudan Savanna of West Africa (Molineaux and Gramiccia 1980). Garnham (1948) found that 
the most striking feature of the disease in children was the failure to find any apparent 
deterioration in general health, both in the initial and in the continuing malaria infection. He 
commented that "with the exception of occasional attacks of slight fever the children were well" 
and noted that it was remarkable how little fever accompanied the infection; only 10% of the 
total cases could be classified as severe. All children in his study were infected by the age of one 
year. 
McGregor and Smith ( 1952) found that malarial pyrexia ceased to be common around the fourth 
year of life and that the number of parasites per I 00 fields of thick blood films was maximal in 
very young children (under I year) and declined progressively in the older age groups. Miller 
( 1958) in Liberia found that the clinical threshold counts for P. falciparum in adults ranged from 
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30 to 4550/mm3 and the mean count for all attacks was I 644/mm3 • The clinical threshold is the
parasite density which produces symptoms (Molineaux 1988); it rises as immunity is acquired. 
The difference in the clinical picture produced hy infection with the same parasite in the same 
region over a period of time, and in different parts of the same continent, is probably related to 
differences in epidemiology and immunity. The epidemiological pattern of malaria within a 
community can vary rrom country to country and, within countries, from area to area. 
Macdonald ( 1957) drew attention to the two extremes in which the infection may be present and 
appropriately termed them unstable and stable. The unstable form occurs when endemicity is 
normally low but where transmission may become intense for brief periods. Characteristically 
the resultant malaria shows substantial seasonal swings in incidence and a capacity swiftly to 
become epidemic given suitable conditions. It is in this form that malaria exacts its greatest toll 
in terms of illness and mortality and its effects are easily discernible at all ages within the 
community. Stable malaria, on the other hand, occurs when endemicity is high and where 
inhabitants are exposed to multiple infections in the course of each year. In such circumstances 
the epjdemiological presentation remains remarkably constant year after year over long periods 
of time and its effects are most noticable in the young child section of the population. Macdonald 
considered that a major result of the epidemiological characteristics of malaria in any area was 
the degree of communal immunity possessed by the population. Where malaria is unstable 
communal immunity is low. save perhaps in periods immediately following an epidemic episode; 
where it is stable communal immunity is high. 
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The results of this study are in contrast to what is expected for a highly endemic, stable malaria 
area. Rather, the findings presented here are more representative of a population subjected to 
epidemic malaria, with little or no immunity to infection. Epidemiologic observations (Sharp et
al 1988; Sharp 1991) in this area are consistent with this. This change from an endemic situation 
in the 1930s to an epidemic one presently is probably the direct result of an effective malaria 
control programme of long standing. 
The common symptoms in the patients were all non-specific, many of which occur in other 
infections such as typhoid fever. This small study shows that the presence of a combination of 
common symptoms may be useful to field workers in selecting individuals for examination of 
blood smears in mass screening programmes. However, this needs to be validated by testing 
these symptoms in patients presenting to a clinic for attention for these complaints during the 
peak malaria season, using the positive blood slide as a gold standard. Respiratory and gastro­
intestinal symptoms were commonly found (Figure 3). The presence of a soft splenomegaly in 
almost half the patient<; is a useful clue to diagnosis. Fever, headache, rigors and splenomegaly 
commonly observed in this study were also frequent presenting features in the two previous 
South African studies (Eales 1972; Jairam et al 1990). Similar results have been reported from 
other southern African countries (Table II), like Zimbabwe (Basset et al 1991; Stein and Gelfand 
1985; Schmitz and Gelfand 1976) and Tanzania (Mkawagile and Kihamia 1986). These 
observations also concur with that of Goldstein ( 1968) in his study of non-immune American 
soldiers in Vietnam (Table II). 
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Jaundice is common in adult patients, panicularly those with severe falciparum malaria, but is 
uncommon in African children (Warrell and Francis 1991 ). Apart from jaundice, signs of hepatic 
uysfunction are unusuai: clinical signs of liver failure are never seen unless there is concomitant 
viral hepatitis (White and Warrell 1988). Tender enlargement of the liver and spleen is a 
common finding in all human malarias, especially in young children and non-immune adults. 
Table II: Commonest symptoms with P. falciparum infection 
studies. 
Commonest symptoms ( % ) Country 
Headache(86), weakness(79), fever(73) Zimbabwe 
Fever(93), headache(44), vomiting(40) Zimbabwe 
Headache(73), vomiting(39), abdominal pain(38) Zimbabwe 
Fever(90), headache(95), myo-arthralgia (90) Tanzania 
Fever(lOO), headache( I 00), myalgia(75) Vietnam 
Fever(88), headache(72). rigors(5 I) RSA 
Fever(90), headache(70), rigors(68) RSA 
Headache(IOO), rigors(98), myalgia(93) KwaZulu 
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Proteinuria and haematuria were also common. Mild proteinuria may occur with any febrile 
illness. In malaria the deposition of immune complexes on the glomerular basement membrane 
may result in an acute nephritis with resultant haematuria and proteinuria. Haematuria may also 
he a result of Schistosoma haematobium infection of the hladder. This was not investigated in 
our patients, though it is well documented that adjacent districts in Northern KwaZulu have a 
high prevalence of S. haematobium infection (Schutte et al 1981). 
Cerebral malaria has a multitude of neurological manifestations, including confusion, delirium, 
psychoses, convulsions, coma, meningism, involuntary movements and other focal neurological 
phenomena. Cerebellar signs have been described by several workers during different stages of 
the disease. A delayed cerebellar syndrome following successful treatment of falciparum malaria 
has been described by De Silva et al ( 1988) and Senanayake ( 1987). It is uncertain whether this
is a consequence of chloroquine therapy or a sequelae of the infection. llangasekera and De 
Sylva ( 1976) also described two patients with an acute cerebellar syndrome { ·curring during a1. 
acute attack of falciparum malaria. 
Several questions arise from the previous re" ms of cerebellar involvement in falciparum 
malaria. The first one is whether this clinical pie re is a delayed syndrome following therapy 
of the infection or whether it arises during the acu, 1ttack. In our patients, it was believed to 
be the latter rather than the former (Soni and Sharp I';. 1). The second question is whether this 
clinical entity occurs out-;ide of Sri Lanka, as all previous , ·,e reports have originated from Sri 
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Lanka. It has been suggested by Senanayake ( 1987) that if this picture is confined to Sri Lanka, 
then a mutant strain of falciparum may be responsible. However, this seems less likely if a 
similar condition is seen as far away as South Africa. 
The possible pathogenic mechanisms for this syndrome remain undetermined. The possibility of 
a drug effect is unlikely, as no common drug was given to all three of our patients. Direct 
invasion of the central nervous system by the organism might damage the cerebellar system by 
causing vascular occlusion, haemorrhage or inflammation. This could be likely in our patients 
as all were ill and toxic during the episode of cerebellar disease. Vascular occlusion may be the 
result of adhesion of infected cells to endothelium, which is mediated by ICAM-1 and Tumour 
necrosis factor. However, it seems unlikely to be the mechanism responsible in those patient-; 
previously reported with a delayed cerebellar syndrome where there was a delay of 21-26 days 
between the fever and the ataxia, which occurred weeks after treatment of the acute infection. 
In those cases an immune-mediated mechanism would probably be more likely. The possibility 
of the malarial episode in some way activating a dormant neurotropic virus which subsequently 
produces the cerebellar damage cannot be excluded (Senanayake 1987). 
5.2 HAEMATOLOGY 
Anaemia is a prominent feature of the infection. The combination of haematuria and anaemia 
suggests red cell destruction as the primary cause of the anaemia; however no correlation was 
observed between malaria parasite density and haemoglobin level. This observation concurs with 
the results of Olweny et al ( 1985). The mechanisms of anaemia are both multifactorial and 
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complex; including destruction of the red cell by the parasite, immune mediated haemolysis, 
non-immune mediated haemolysis, disseminated intravascular haemolysis, dyserythropoiesis and 
a reduction in serum iron and transferrin (Pasvol 1986; Phillips et al 1986). 
Leucopenia has been reported in 30% (Goldstein 1968) and 33% (Reiley and O'Neill 1971) of 
American soldiers in Vietnam suffering from acute P. falciparum infections and occurred with 
a similar frequency (24 % ) in our patients. Typhoid fever, which is also endemic to this study 
area, can also produce a leucopenia. Thus a low white cell count in the presence of a febrile 
illness is a less sensitive indicator of malaria. Leucocytosis was also uncommon in the above 
studies (Goldstein 1968; Reiley and O'Neill 1971) of uncomplicated malaria and its occurrence 
should raise the possibility of another disease. 
5.3 LIVER BIOCHEMISTRY 
Some impairment of liver function is common in malaria (White and Warrell 1983), but true 
liver failure is unusual. Unfortunately, assessment of 'liver function' by measurement of blood 
concentrations of biliruhin and the liver-related enzymes is notoriously imprecise, particularly 
when there is coexisting haemolysis. The measurable consequences of hepatic dysfunction in 
malaria are coagulation abnormalities, hypoalbuminaemia and reduced metabolic clearance of 
many substances (White 1986). Serum enzyme assays such as the aminotransferases are very 
sensitive indicators of tissue-cell damage, particularly in the liver. 
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Sadun er al ( 1966) were one of the first groups of investigators to use serum enzymes to detect 
cell lesions in malaria. They investigated American military personnel returning from Vietnam 
with P. falciparum malaria and reported a significant increase in infected patients over values 
in uninfected control individuals in serum ALT levels but not in serum AST levels. The former 
enzyme is generally accepted as being more specific for liver lesions than the latter one. 
Serum biochemical changes were also measured by Sadun er al ( 1966) in infected and non­
infected indigenous Thai subjects living in an endemic area. Significant serum increases in both 
ALT and AST were seen in infected individuals. AST is present in erythrocytes, heart, kidney 
and skeletal muscle as well as liver; ALT is a more sensitive and specific indicator of 
hepatocellular damage than is AST (Preisig et al 1992). Deller et al ( 1967) found that elevated 
serum enzymes were associated with either liver tenderness or gastrointestinal symptoms, or 
both. The liver biopsy findings were abnormal in almost all the cases, whether or not the serum 
enzymes were increased. There was a lack of cell necrosis but increased hepatocyte nuclear and 
cytoplasmic activity was observed, together with Kupffer cell hyperplasia and some mononuclear 
infiltration. 
As expected, this study showed a greater number of patients(64%) than control subjects (13.5%) 
with a low serum albumin. Hypoalbuminaemia is an important index of hepatic dysfunction. 
Lower serum albumin levels were also observed in the infected Thai patients (Sadun et al 1966). 
However, only 2 of 58(3.5%) patients in our study had an elevated serum ALT compared to 15
of 58(26 % ) patients who had an elevated AST. Considering the high proportion of infected 
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individuals who had an elevated LDH(83%), it is more likely that the enzyme elevation is 
secondary to destruction of the parasitised erythrocyte than hepatic involvement. LOH is found 
in heart, skeletal muscle, liver. kidney, brain and erythrocytes. 
In most patients with falciparum malaria the plasma concentration of total bilirubin is increased, 
implying haemolysis. In this study it was elevated in 33 % of patients compared to none in the 
control group. The most commonly present biochemical indicators of P. falciparum infection 
were elevated LDH(83%) and hypoalbuminaemia(64%). 
5 .4 HAPTOGLOBINS 
Previous studies have demonstrated low levels of serum haptoglobins in regions of Africa where 
the prevalence of malaria is high (Trape et al 1985; Hill et al 1987). These studies suggest that 
in regions where malaria is endemic the prevalence of hypohaptoglobinaemia could be a useful 
indicator of the parasitic index; additionally it is much easier to monitor. Rougemont et al ( 1988) 
have demonstrated the reappearance of detectable levels of haptoglobin after antimalarial therapy. 
They also demonstrated a correlation between the haptoglobin index (the proportion of subjects 
in a given group with concentrations of less than I 0%) and the parasite index and parasite load. 
In the study by Trape et al (1985) in the Congo, the proportion of individuals with 
ahaptoglobinaemia reached 42. 1 % in those heavily infected. The present study showed that 44 % 
of infected individuals had low levels of haptoglobins in an area with seasonal malaria 
transmission. Blumberg er al ( 1963) showed a decrease in serum haptoglobin level to correlate 
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with the fall in haemoglobin level in a group of seven patients. The results in Chapter 4 do 
appear to show a relationship between the fall in the haemoglobin and the serum haptoglobin. 
However, this could not he quantified because several patients had undetectable levels of 





Sharp ( 1988 and 1991) has shown that the pattern of malaria transmission in the northern areas 
of Natal/KwaZulu has changed from one of endemic malaria to epidemic transmission with peaks 
during the months of March and April. This study demonstrates that the clinical profile of 
Plasmodium falciparum infection in the region has also altered. 
The clinical manifestations of falciparum malaria in the Natal/KwaZulu area prior to institution 
of the of the malaria control programme were similar to that seen in other malarious areas 
(Swellengrebel 1931). However in the present study, severe and complicated malaria, as 
recently defined by the World Health Organisation (Warrell et al 1990), was not common at 
presentation in this select (clinic) population. The severity of infection ranged from a flu-like 
illness to high fever with convulsions. It must be noted that since this study was performed at 
a primary care level, all the features of severe and complicated malaria could not be conclusively 
diagnosed, eg. renal failure, acid-base disturbances. 
Parasite loads were generally low in most patients in this study. However, those patients with 
low parasite loads had prominent symptoms of infection; the low parasitaemia also suggests that 
they may he presenting early in the infection for medical attention. This would imply a much 
lower level of acquired immunity than that suggested by Swellengrehel et al in the same area in 
42 
1931 . The change in clinical profile, coupled with the changing epidemiology, is a strong 
indicator that the malaria control programme in the region has had an impact on the disease. 
The lack of naturally-acquired immunity needs to be verified by further studies, eg. by 
measuring levels of circumsporozoite antibodies in patients and the local population. The loss 
of the semi-immune status of the population has implications for epidemics of malaria infection. 
Local outbreaks of infection, usually following heavy rainfall, will result in considerable 
morbidity and mortality; all age groups will be prone to symptomatic infection, with or without 
complications. This was probably the basis for the high case rates in 1987 and 1988 following 
flooding of this area. Epidemics have been reported in areas in which malaria had been reduced 
to a very low level through control measures. Examples are Sri Lanka in I 965, the Gezirah, 
Sudan. in 1975, and the Adana plain, Turkey, in 1977 (Molineaux 1988). Typically, 
transmission had been controlled mainly by the spraying of residual insecticides whose effect was 
temporary only. 
The combination of common symptoms found in our patients are a useful clue for field workers 
carrying out mass blood screening examinations. The World Health Organisation and UNICEF 
currently recommend treatment of clinical malaria by village health workers and others as the 
optimum strategy for the control of malaria in children (Greenwood et al 1988). 
Valuable indirect biochemical indicators of malaria infection include an elevated LOH and 
reduced haptoglobin levels, which are both sensitive and may be of value in rapid diagnosis. 
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However. a diagnosis cannot he confirmed on these indicators alone and microscopic 
examination of a blood film remains the only confirmatory test. Furthermore, equipment 
required to measure these biochemical products is usually unavailable in areas where the disease 
is prevalent. 
This study also shows that a greater number of patients had an elevated AST compared with 
ALT; this suggests that the enzyme elevation originates from the parasitised erythrocyte rather 
than the hepatocyte. 
Finally, the comments by Najera ( 1986) on malaria control are fitting to conclude this 
dissertation: 
"Research in malaria is already producing promising results in the development 
of new drugs, new methods of diagnosis, and possible means of active 
immunisation against malaria. However, the main obstacle to malaria control has 
not been the lack of technology or even knowledge, but the difficulties of 
. adapting existing knowledge to local situations and making optimal use of the 
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